Alfonso Gúrpide

3.7k total citations · 1 hit paper
75 papers, 2.5k citations indexed

About

Alfonso Gúrpide is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alfonso Gúrpide has authored 75 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 17 papers in Molecular Biology. Recurrent topics in Alfonso Gúrpide's work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (16 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Alfonso Gúrpide is often cited by papers focused on Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (16 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Alfonso Gúrpide collaborates with scholars based in Spain, United States and France. Alfonso Gúrpide's co-authors include José Luis Perez‐Gracia, Ignacio Melero, Salvador Martín‐Algarra, José M. López-Picazo, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, Álvaro González, Kurt A. Schalper, Carlos Alfaro and Pedro Berraondo and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alfonso Gúrpide

74 papers receiving 2.5k citations

Hit Papers

Neoadjuvant nivolumab modifies the tumor immune microenvi... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
    2019 449 citations María E. Rodríguez-Ruiz, Pedro Berraondo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Gúrpide Spain 23 1.5k 1.0k 782 511 392 75 2.5k
Thomas A. Puchalski United States 24 1.5k 1.0× 834 0.8× 789 1.0× 905 1.8× 413 1.1× 51 2.8k
Alexander Guminski Australia 30 3.1k 2.1× 1.2k 1.2× 860 1.1× 1.1k 2.2× 350 0.9× 114 4.2k
Feifei Teng China 21 1.6k 1.1× 674 0.6× 669 0.9× 375 0.7× 238 0.6× 54 2.3k
Mehmet Altan United States 24 2.1k 1.4× 885 0.8× 559 0.7× 364 0.7× 200 0.5× 121 2.5k
Leila Khoja United Kingdom 20 1.7k 1.1× 612 0.6× 403 0.5× 416 0.8× 388 1.0× 50 2.1k
Roxana Dronca United States 33 2.8k 1.8× 771 0.7× 1.4k 1.8× 1.0k 2.0× 290 0.7× 109 3.8k
Justine V. Cohen United States 22 2.4k 1.6× 838 0.8× 583 0.7× 516 1.0× 100 0.3× 96 3.4k
Shinzo Takamori Japan 22 1.3k 0.9× 1.2k 1.1× 493 0.6× 455 0.9× 233 0.6× 106 2.6k
Anna Maria Di Giacomo Italy 31 2.8k 1.9× 1.1k 1.0× 1.6k 2.0× 1.1k 2.2× 151 0.4× 111 4.0k
Yusri Elsayed United States 22 1.1k 0.7× 606 0.6× 422 0.5× 1.1k 2.1× 208 0.5× 51 2.4k

Countries citing papers authored by Alfonso Gúrpide

Since Specialization
Citations

This map shows the geographic impact of Alfonso Gúrpide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Gúrpide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Gúrpide more than expected).

Fields of papers citing papers by Alfonso Gúrpide

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Gúrpide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Gúrpide. The network helps show where Alfonso Gúrpide may publish in the future.

Co-authorship network of co-authors of Alfonso Gúrpide

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Gúrpide. A scholar is included among the top collaborators of Alfonso Gúrpide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Gúrpide. Alfonso Gúrpide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maza, Maria D. Fenor de la, Guillermo Villacampa, B. Miñana, et al.. (2023). First-line Management of Metastatic Urothelial Cancer: Current and Future Perspectives After the EV-302 and CheckMate-901 Studies. Clinical Genitourinary Cancer. 22(2). 330–335. 6 indexed citations
2.
Sanmamed, Miguel F., et al.. (2023). PSA reactivity in extracellular microvesicles to commercial immunoassays. Clinica Chimica Acta. 543. 117303–117303. 5 indexed citations
3.
Alegre, Estíbaliz, Gorka Alkorta‐Aranburu, Ana Patiño‐García, et al.. (2019). The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients. Disease Markers. 2019. 1–7. 11 indexed citations
4.
5.
6.
Alegre, Estíbaliz, Juan P. Fusco, Patricia Restituto, et al.. (2016). Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value. Tumor Biology. 37(10). 13687–13694. 34 indexed citations
7.
Peñas, R. de las, Ana Blasco, Javier de Castro, et al.. (2016). SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016). Clinical & Translational Oncology. 18(12). 1237–1242. 8 indexed citations
8.
Labiano, Sara, Asís Palazón, Elixabet Bolaños, et al.. (2015). Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism. OncoImmunology. 5(1). e1062967–e1062967. 52 indexed citations
9.
García‐Velloso, María José, María D. Lozano, Tania Labiano, et al.. (2014). Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 41(11). 2058–2065. 69 indexed citations
10.
Sádaba, Belén, Miguel Ángel Campanero, José Ramón Azanza Perea, et al.. (2014). Randomized Pharmacokinetic Study Comparing Subcutaneous and Intravenous Palonosetron in Cancer Patients Treated with Platinum Based Chemotherapy. PLoS ONE. 9(2). e89747–e89747. 13 indexed citations
11.
Lozano, María D., Tania Labiano, Isabel Zudaire, et al.. (2014). Variations in Molecular Profile in NSCLC Can Be Analyzed Using Cytological Samples. International Journal of Surgical Pathology. 23(2). 111–115. 8 indexed citations
12.
Ochoa, María C., Jessica Fioravanti, Inmaculada Rodríguez, et al.. (2012). Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein. Cancer Research. 73(1). 139–149. 39 indexed citations
13.
Alfaro, Carlos, Natalia Suárez, Iván Martínez‐Forero, et al.. (2011). Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation. PLoS ONE. 6(3). e17922–e17922. 34 indexed citations
14.
Porta, R., J.M. Sánchez-Torres, Luis Paz‐Ares, et al.. (2010). Brain metastases from lung cancer responding to erlotinib: the importance ofEGFRmutation. European Respiratory Journal. 37(3). 624–631. 247 indexed citations
15.
Perez‐Gracia, José Luis, et al.. (2010). Selection of extreme phenotypes: the role of clinical observation in translational research. Clinical & Translational Oncology. 12(3). 174–180. 31 indexed citations
16.
Pardo, J. R., J. Solà, Ángel Panizo, et al.. (2009). Large Cell Carcinoma of the Lung. Applied immunohistochemistry & molecular morphology. 17(5). 383–392. 45 indexed citations
17.
18.
Perez‐Gracia, José Luis, María del Mar Muñoz, Grant Williams, et al.. (2005). Assessment of the value of confirming responses in clinical trials in oncology. European Journal of Cancer. 41(11). 1528–1532. 7 indexed citations
19.
Gúrpide, Alfonso, José Luis Perez‐Gracia, José M. López-Picazo, et al.. (2005). Activity of Gefitinib in Central Nervous System Metastases in Patients with Non–Small-Cell Lung Cancer: Two Case Reports and a Review of the Literature. Clinical Lung Cancer. 7(2). 138–140. 12 indexed citations
20.
Labarga, Pablo, et al.. (1993). [HIV infection in an autonomous Spanish community (La Rioja). Features, trends and conclusions applicable to other regions].. PubMed. 10(7). 399–402. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas A. Puchalski Breakdown of academic impact, for papers by Alexander Guminski Breakdown of academic impact, for papers by Feifei Teng Breakdown of academic impact, for papers by Mehmet Altan Breakdown of academic impact, for papers by Leila Khoja Breakdown of academic impact, for papers by Roxana Dronca Breakdown of academic impact, for papers by Justine V. Cohen Breakdown of academic impact, for papers by Shinzo Takamori Breakdown of academic impact, for papers by Anna Maria Di Giacomo Breakdown of academic impact, for papers by Yusri Elsayed
Rankless by CCL
2026